Cover Image

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Shu Jiang, Steven E. Arnold, Rebecca A. Betensky
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
by: Xiaotian Chen, et al.
Published: (2025)

Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial
by: Corine Baayen, et al.
Published: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
by: Marco Ratta, et al.
Published: (2026)

Sequential Event Rate Monitoring
by: Dong‐Yun Kim, et al.
Published: (2026)

Futility Monitoring in Clinical Trials
by: Ana M. Ortega‐Villa, et al.
Published: (2025)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
by: Amitay Kamber, et al.
Published: (2025)

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis
by: Ruoyuan Qian, et al.
Published: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
by: Liwen Wu, et al.
Published: (2025)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
by: Xi Fang, et al.
Published: (2025)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
by: Marianthie Wank, et al.
Published: (2024)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
by: Xinran Huang, et al.
Published: (2024)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
by: Yeonhee Park, et al.
Published: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)

Comments on “Sample Size Adaptation Designs and Efficiency Comparison With Group Sequential Designs”
by: Meinhard Kieser, et al.
Published: (2025)

The Design of Large‐Scale Plasma Donation Trials
by: Kecheng Li, et al.
Published: (2025)

An Augmented Likelihood Approach Incorporating Error‐Prone Auxiliary Data Into a Survival Analysis
by: Noorie Hyun, et al.
Published: (2025)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
by: Rebecca B. Silva, et al.
Published: (2024)

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule
by: Juhee Lee, et al.
Published: (2024)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
by: Alessandra Serra, et al.
Published: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
by: Gi‐Ming Wang, et al.
Published: (2026)

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
by: Daniel Backenroth, et al.
Published: (2026)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
by: Yuwei Cheng, et al.
Published: (2026)

BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes
by: Cheng‐Han Yang, et al.
Published: (2026)

The Whys, Whens, and Hows of Futility Monitoring
by: Karen M. Higgins, et al.
Published: (2025)

An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing With Concurrent Controls in Platform Trials
by: Tianyu Zhan, et al.
Published: (2025)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
by: Yuan Li, et al.
Published: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
by: Yingjie Qiu, et al.
Published: (2026)

Modeling correlated pairs of mammogram images
by: Shu Jiang, et al.
Published: (2024)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
by: David S. Robertson, et al.
Published: (2025)

Designing Stepped Wedge Cluster Randomized Trials With a Baseline Measurement of the Outcome
by: Kendra Davis‐Plourde, et al.
Published: (2025)

Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data
by: Guoqiao Wang, et al.
Published: (2024)

On the Inclusion of Non‐Concurrent Controls in Platform Trials With an Interim Analysis
by: Pavla Krotka, et al.
Published: (2026)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
by: Hyejung Jung, et al.
Published: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Moka Komaki, et al.
Published: (2026)

A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives
by: Antonio Olivas‐Martinez, et al.
Published: (2026)

Score Test for Functional Markov Process With Image Predictor
by: Yang Wang, et al.
Published: (2025)

Sequential Parallel Comparison Design for Assessing Induction, Maintenance, Long‐Term, and Other Treatment Effects on a Binary Endpoint
by: Hui Quan, et al.
Published: (2026)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
by: Antonio D'Alessandro, et al.
Published: (2026)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
by: Elizabeth L. Turner, et al.
Published: (2026)